Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Diversigen Teams Up With Korea-based BioCore | Contract Pharma
Breaking News

Diversigen Teams Up With Korea-based BioCore

Together will bring metagenomic/microbiome services to Korea

Diversigen, a provider of microbiome analysis services, has partnered with BioCore, a bioanalytical contract research organization (CRO), based in Seoul, South Korea. This partnership expands BioCore’s portfolio, adding Diversigen’s advanced microbiome/metagenomics analysis to BioCore’s laboratory service offerings, and facilitates Diversigen’s entry into the growing Asian pharmaceutical market.

“BioCore offers the best in a strategic partner—deep domain expertise, a solid reputation, and an innovative approach to serving their customers,” said Caroline Popper, chief executive officer, Diversigen. “We look forward to helping BioCore and their customers gain competitive advantage through solutions designed to accelerate and transform discovery research, accelerate otherwise lengthy clinical trials, and capitalize on the diverse opportunities of the microbiome.”

H.S. Choie, president and chief executive officer, BioCore, said, “Our partnership with Diversigen gives BioCore an opportunity to broaden our reach in the Korean pharmaceutical market and provide our customers with access to the leading scientists in the exploding field of microbiome research.”  

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters